Skip to main content

Table 2 Results of percutaneous transjejunal biliary intervention (PTJBI) for benign biliary strictures and stones

From: Two decades of percutaneous transjejunal biliary intervention for benign biliary disease: a review of the intervention nature and complications

Benign strictures and stones
  No. of interventions per patient No. of interventions per year Interval between biliary-enteric anastomosis and initial PTJBI (weeks) Interval between interventions (weeks)
  n (%) Interventions Mean Range Mean Range Mean Range Mean Range
Diagnosis
Post-cholecystectomy injury 39 (62%) 272 7 1–40 1.45 0.29–3.33 202.4 2.7–1,279.6 49.3 0.3–314.1
Recurrent pyogenic cholangitis 6 (9.5%) 90 15 3–40 2.34 1.60–3.25 69.5 3.7–253.1 19.5 14.0–32.9
Primary sclerosing cholangitis 6 (9.5%) 39 6 2–13 0.90 0.40–1.30 40.3 2.3–211.3 79.4 36.0–79.4
Caroli’s disease 7 (11%) 73 10 1–32 1.40 0.30–3.56 130.7 3.9–498.0 87.9 14.3–223.4
Other 5 (8%) 20 4 1–7 2.17 1.00–3.50 44.9 4.9–149.1 20.2 2.9–36.8
Total 63 494 8   1.7 (p = 0.016)   98.0 (p > 0.05)   51.3 (p = 0.041)  
Bismuth classificationa
Bismuth I and II 18 (46.2%) 90 5 1–17 1.30 0.30–3.00 312.3 2.7–1279.6 57.7 11.2–228.1
Bismuth III 8 (20.5%) 47 6 1–14 1.31 0.29–2.00 212.8 6.0–770.9 69.5 0.3–314.1
Bismuth IV 13 (33.3%) 135 10 1–40 1.78 1.00–3.33 84.0 6.9–209.6 26.6 9.4–57.1
Total 39 272 7   1.45 (p > 0.05)   202.4 (p > 0.05)   49.3 (p > 0.05)  
Dominant underlying pathology
Stone group 15 (23.8%) 118 8 1–32 1.23 0.30–3.56 78.1 2.3–498.0 43.9 0.3–314.1
Stricture group 48 (76.2%) 376 8 1–40 1.69 (p = 0.045) 0.29–3.50 (p = 0.031) 178.3 2.7–1,279.6 72.8 (p = 0.016) 2.9–223.4
  1. a Post-cholecystectomy injury patients only